153 related articles for article (PubMed ID: 36111920)
1. In vitro protective effect of miR-181d-5p in high glucose‑induced human retinal microvascular endothelial cells by targeting the angiogenic factor VEGFA.
Wang F; Yu C
Eur Rev Med Pharmacol Sci; 2022 Sep; 26(17):6199-6207. PubMed ID: 36111920
[TBL] [Abstract][Full Text] [Related]
2. A novel regulatory network of linc00174/miR-150-5p/VEGFA modulates pathological angiogenesis in diabetic retinopathy.
Wang JJ; Wu KF; Wang DD
Can J Physiol Pharmacol; 2021 Nov; 99(11):1175-1183. PubMed ID: 34081870
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-199a-3p inhibits angiogenesis by targeting the VEGF/PI3K/AKT signalling pathway in an in vitro model of diabetic retinopathy.
Wang L; Liu WX; Huang XG
Exp Mol Pathol; 2020 Oct; 116():104488. PubMed ID: 32622012
[TBL] [Abstract][Full Text] [Related]
4. Apigenin inhibits angiogenesis in retinal microvascular endothelial cells through regulating of the miR-140-5p/HDAC3-mediated PTEN/PI3K/AKT pathway.
Fu C; Peng J; Ling Y; Zhao H; Zhao Y; Zhang X; Ai M; Peng Q; Qin Y
BMC Ophthalmol; 2023 Jul; 23(1):302. PubMed ID: 37415101
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of circ-UBAP2 ameliorates oxidative stress and dysfunctions of human retinal microvascular endothelial cells (hRMECs) via miR-589-5p/EGR1 axis.
Jiewei Y; Jingjing Z; Jingjing X; Guilan Z
Bioengineered; 2021 Dec; 12(1):7508-7518. PubMed ID: 34608841
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of Malat1 alleviates high-glucose-induced angiogenesis through regulating miR-205-5p/VEGF-A axis.
Tan A; Li T; Ruan L; Yang J; Luo Y; Li L; Wu X
Exp Eye Res; 2021 Jun; 207():108585. PubMed ID: 33887222
[TBL] [Abstract][Full Text] [Related]
7. Circular RNA COL1A2 promotes angiogenesis via regulating miR-29b/VEGF axis in diabetic retinopathy.
Zou J; Liu KC; Wang WP; Xu Y
Life Sci; 2020 Sep; 256():117888. PubMed ID: 32497630
[TBL] [Abstract][Full Text] [Related]
8. MSC-derived exosomal lncRNA SNHG7 suppresses endothelial-mesenchymal transition and tube formation in diabetic retinopathy via miR-34a-5p/XBP1 axis.
Cao X; Xue LD; Di Y; Li T; Tian YJ; Song Y
Life Sci; 2021 May; 272():119232. PubMed ID: 33600866
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of miR-192-5p inhibits the ELAVL1/PI3Kδ axis and attenuates microvascular endothelial cell proliferation, migration and angiogenesis in diabetic retinopathy.
Fu XL; He FT; Li MH; Fu CY; Chen JZ
Diabet Med; 2023 Sep; 40(9):e15077. PubMed ID: 36861382
[TBL] [Abstract][Full Text] [Related]
10. MiR-203a-3p inhibits retinal angiogenesis and alleviates proliferative diabetic retinopathy in oxygen-induced retinopathy (OIR) rat model via targeting VEGFA and HIF-1α.
Han N; Xu H; Yu N; Wu Y; Yu L
Clin Exp Pharmacol Physiol; 2020 Jan; 47(1):85-94. PubMed ID: 31408201
[TBL] [Abstract][Full Text] [Related]
11. The mechanism by which crocetin regulates the lncRNA NEAT1/miR-125b-5p/SOX7 molecular axis to inhibit high glucose-induced diabetic retinopathy.
Chen Q; Xi X; Ma J; Wang X; Xia Y; Wang X; Deng Y; Li Y
Exp Eye Res; 2022 Sep; 222():109157. PubMed ID: 35718188
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of histone deacetylase SIRT1 exerts an antiangiogenic role in diabetic retinopathy via miR-20a elevation and YAP/HIF1α/VEGFA depletion.
Pan Q; Gao Z; Zhu C; Peng Z; Song M; Li L
Am J Physiol Endocrinol Metab; 2020 Nov; 319(5):E932-E943. PubMed ID: 32776826
[TBL] [Abstract][Full Text] [Related]
13. LncRNA SNHG1 targets miR-340-5p/PIK3CA axis to regulate microvascular endothelial cell proliferation, migration, and angiogenesis in DR.
He FT; Fu XL; Li MH; Fu CY; Chen JZ
Kaohsiung J Med Sci; 2023 Jan; 39(1):16-25. PubMed ID: 36484399
[TBL] [Abstract][Full Text] [Related]
14. LncRNA-MALAT1 promotes neovascularization in diabetic retinopathy through regulating miR-125b/VE-cadherin axis.
Liu P; Jia SB; Shi JM; Li WJ; Tang LS; Zhu XH; Tong P
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988072
[No Abstract] [Full Text] [Related]
15. MicroRNA-409-5p promotes retinal neovascularization in diabetic retinopathy.
Wang Y; Lin W; Ju J
Cell Cycle; 2020 Jun; 19(11):1314-1325. PubMed ID: 32292119
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow mesenchymal stem cells-derived exosomal miR-185-5p plays a protective role in high-glucose stimulated human retinal microvascular endothelial cells in vitro by regulating CXCL8.
Zhou L; Wang W
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(15):186-192. PubMed ID: 38279450
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA MALAT1 participates in the pathological angiogenesis of diabetic retinopathy in an oxygen-induced retinopathy mouse model by sponging miR-203a-3p.
Yu L; Fu J; Yu N; Wu Y; Han N
Can J Physiol Pharmacol; 2020 Apr; 98(4):219-227. PubMed ID: 31689123
[TBL] [Abstract][Full Text] [Related]
18. miR-139-5p promotes neovascularization in diabetic retinopathy by regulating the phosphatase and tensin homolog.
Zhang Z; Song C; Wang T; Sun L; Qin L; Ju J
Arch Pharm Res; 2021 Feb; 44(2):205-218. PubMed ID: 33609236
[TBL] [Abstract][Full Text] [Related]
19. USP14 Regulates ATF2/PIK3CD Axis to Promote Microvascular Endothelial Cell Proliferation, Migration, and Angiogenesis in Diabetic Retinopathy.
He FT; Fu XL; Li MH; Fu CY; Chen JZ
Biochem Genet; 2023 Oct; 61(5):2076-2091. PubMed ID: 36939972
[TBL] [Abstract][Full Text] [Related]
20. hsa_circ_0000047 targeting miR-6720-5p/CYB5R2 axis alleviates inflammation and angiogenesis in diabetic retinopathy.
Liao L; Chen J; Peng S
Arch Physiol Biochem; 2023 Mar; ():1-9. PubMed ID: 36971486
[No Abstract] [Full Text] [Related]
[Next] [New Search]
